BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
BELITE BIO, INC
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$147.34+4.56 (+3.19%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Belite Bio has not reported a dividend
No dividend per share appears in Belite Bio's annual filings since fiscal 2019.